BIOVIE INC. (BIVIW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-180M -120M -60M 0 60M 120M 180M Q2 '16: -432K Q3 '16: -728.8K Q4 '16: -1M Q1 '17: -1.4M Q2 '17: -1.6M Q3 '17: -1.9M Q4 '17: -2M Q1 '18: -2.3M Q2 '18: -2.4M Q3 '18: -2.2M Q4 '18: -2.2M Q1 '19: -2.4M Q2 '19: -2.5M Q3 '19: -2.7M Q4 '19: -2.9M Q1 '20: -2.8M Q2 '20: -2.7M Q3 '20: -2.4M Q4 '20: -4.7M Q1 '21: -7M Q2 '21: -138.1M Q3 '21: -143.2M Q4 '21: -146.8M Q1 '22: -149.6M Q2 '22: -27.3M Q3 '22: -30.5M Q4 '22: -35.4M Q1 '23: -43.4M Q2 '23: -45.1M Q3 '23: -47.1M Q4 '23: -44.4M Q1 '24: -38.4M Q2 '24: -32.2M Q3 '24: -25.4M Q4 '24: -23.9M Q1 '25: -19.2M Q2 '25: -18.1M Q3 '25: -19.2M Q4 '25: -18.2M Q1 '26: -20.6M Q2 '26: -22.7M Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income TTM

-180M -120M -60M 0 60M 120M 180M Q1 '14: -166.2K Q2 '14: -321.9K Q3 '14: -327.2K Q4 '14: -350.5K Q1 '15: -351.5K Q2 '15: -233K Q3 '15: -228.8K Q4 '15: -208.2K Q1 '16: -217K Q2 '16: -431.9K Q3 '16: -728.7K Q4 '16: -1M Q1 '17: -1.2M Q2 '17: -1.3M Q3 '17: -1.6M Q4 '17: -1.8M Q1 '18: -2.3M Q2 '18: -2.4M Q3 '18: -2.2M Q4 '18: -2.2M Q1 '19: -2.4M Q2 '19: -2.4M Q3 '19: -5.8M Q4 '19: 1.3M Q1 '20: 1.8M Q2 '20: -16.7M Q3 '20: -5.5M Q4 '20: -15.2M Q1 '21: -17.9M Q2 '21: -130.2M Q3 '21: -143.1M Q4 '21: -145.5M Q1 '22: -149.5M Q2 '22: -26.1M Q3 '22: -31M Q4 '22: -41.2M Q1 '23: -49.2M Q2 '23: -50.3M Q3 '23: -50.6M Q4 '23: -43.3M Q1 '24: -36.3M Q2 '24: -32.1M Q3 '24: -25.6M Q4 '24: -24.3M Q1 '25: -19M Q2 '25: -17.5M Q3 '25: -18.5M Q4 '25: -17.4M Q1 '26: -19.9M Q2 '26: -22.1M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q1 '14: -163K Q2 '14: -172.8K Q3 '14: -127.7K Q4 '14: -118.8K Q1 '15: -66.7K Q2 '15: -65.4K Q3 '15: -52.6K Q4 '15: -38.5K Q1 '16: -45.3K Q2 '16: -153.6K Q3 '16: -279.7K Q4 '16: -365.4K Q1 '17: -617.8K Q2 '17: -623.6K Q3 '17: -699K Q4 '17: -757.2K Q1 '18: -537.2K Q2 '18: -621.3K Q3 '18: -859.8K Q4 '18: -1.5M Q1 '19: -2.1M Q2 '19: -2.5M Q3 '19: -2.7M Q4 '19: -2.2M Q1 '20: -1.9M Q2 '20: -1.6M Q3 '20: -2.1M Q4 '20: -3.2M Q1 '21: -3.8M Q2 '21: -10.5M Q3 '21: -11.9M Q4 '21: -15.3M Q1 '22: -20.1M Q2 '22: -19M Q3 '22: -25.7M Q4 '22: -29M Q1 '23: -34.8M Q2 '23: -40.3M Q3 '23: -43.2M Q4 '23: -41.1M Q1 '24: -35.2M Q2 '24: -27.9M Q3 '24: -19.3M Q4 '24: -22M Q1 '25: -17.4M Q2 '25: -19M Q3 '25: -18.5M Q4 '25: -14.3M Q1 '26: -20.5M Q2 '26: -19M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 15M 30M 45M Q4 '18: 2.5M Q1 '19: 2.5M Q3 '19: 4.1M Q4 '19: 5.2M Q1 '20: 5.2M Q3 '20: 6M Q4 '20: 13.9M Q1 '21: 13.9M Q3 '21: 23.7M Q4 '21: 25M Q1 '22: 25M Q3 '22: 27.2M Q4 '22: 31.2M Q1 '23: 35.3M Q3 '23: 3.7M Q4 '23: 3.8M Q1 '24: 4.5M Q3 '24: 639.8K Q4 '24: 1.6M Q1 '25: 1.9M Q3 '25: 5.2M Q4 '25: 7.9M Q1 '26: 7.5M Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: 0.00 Q1 '15: 0.00 Q2 '15: 0.00 Q3 '15: 0.00 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: -0.01 Q4 '17: -0.02 Q1 '18: -0.03 Q2 '18: -0.04 Q3 '18: -0.03 Q4 '18: -0.22 Q1 '19: -0.55 Q2 '19: -0.79 Q3 '21: -10.85 Q4 '21: -10.85 Q1 '22: -10.91 Q2 '22: -1.06 Q3 '22: -1.21 Q4 '22: -1.49 Q1 '23: -1.64 Q2 '23: -15.46 Q3 '23: -18.00 Q4 '23: -19.70 Q1 '24: -21.27 Q2 '24: -73.13 Q3 '24: -77.21 Q4 '24: -79.56 Q1 '25: -79.07 Q2 '25: -14.50 Q3 '25: -8.48 Q4 '25: -4.70 Q1 '26: -3.89 Q2 '26: -3.15 Q2 '15 Q4 '16 Q2 '18 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.